However, in the present study, the percentage of patients having CTCs with JUNB expression was higher than those with CXCR4 compared to breast cancer cases, implying that JUNB could be a very important player in metastatic procedure in NSCLC patients. This evidence concerns the gene JUNB and non-small cell lung carcinoma.